Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

@inproceedings{Tontodonati2015CostOH,
  title={Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort},
  author={Monica Tontodonati and Giovanni Cenderello and Benedetto Maurizio Celesia and Michele Trezzi and Tamara Ursini and Andrea Costantini and Domenico Marra and Ennio Polilli and Corrado Catalani and Luca Butini and Federica Sozio and Elena Mazzotta and Antonina Sciacca and Giuliano Rizzardini and Lamberto Manzoli and A. Cozzi-lepri and Giustino Parruti},
  booktitle={ClinicoEconomics and outcomes research : CEOR},
  year={2015}
}
BACKGROUND As HIV infection turned into a chronic treatable disease, now ranking as one of the most costly in medicine, long-term sustainability of highly active antiretroviral treatment (HAART) expenses became a major issue, especially in countries with universal access to care. Identification of determinants of higher HAART costs may therefore help in controlling costs of care, while keeping high levels of retention in care and viral suppression. METHODS With this aim, we enrolled a large… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 26 references

A multifactorial risk score to evaluate baseline and antiretroviral-related toxicities relative to the costs of current antiretroviral regimens in a cohort of HIV-infected patients

  • M Tontodonati, F Sozio, F Vadini
  • Oral communication OC40 presented at the Ninth…
  • 2012

Similar Papers

Loading similar papers…